T-Cell Lymphoma

There are many types of Lymphoma, which combines Latin and Greek roots to mean a "water-like tumor".

It is a type of cancer that affects the lymphatic system, specifically attacking white blood cells called lymphocytes.

The body is simply amazing!

When cells are produced in the bone marrow, they enter the bloodstream and know exactly their destination and job to keep the body functioning correctly. Every cell has a purpose. When these cells are created, they are “immature” and develop into functioning cells. All immature cells are potentially cancerous because, at that moment in time, they have no purpose. The body is designed to function at a very high level, so when a cell does not develop properly, it can become cancerous.

What is T-Cell Lymphoma?

LT-cell lymphoma is a rare, aggressive, or slow-growing type of non-Hodgkin lymphoma that develops in T-cells—a type of white blood cell vital for fighting off infections. Symptoms, treatment, and outlook heavily depend on the specific subtype and whether it originates in the skin or the lymphatic system.


There are over 20 distinct subtypes, categorized by how quickly they grow:


  • Cutaneous T-Cell Lymphoma (CTCL): Primarily affects the skin. The most common forms are mycosis fungoides (slow-growing) and Sézary syndrome (more advanced).
  • Peripheral T-Cell Lymphoma, Unspecified (PTCL-U): A group of aggressive (fast-growing) lymphomas that typically start in the lymph nodes.
  • Anaplastic Large Cell Lymphoma (ALCL): Can be either cutaneous or systemic and tends to be fast-growing but treatable, often featuring a specific protein known as CD30.
  • T-Cell Lymphoblastic Lymphoma: A highly aggressive, fast-growing subtype that often starts in the thymus and typically affects children and young adults.

Access to state-of-the-arts medical care is critical for the outcome of a cure.

Because there are so many subtypes, there is no one-size-fits-all treatment. Typical treatments include:


  • Skin-Directed Therapies: For cutaneous lymphoma, treatments often include medicated skin creams, phototherapy (light therapy), or radiation therapy.
  • Chemotherapy: Often used as a first-line treatment for aggressive, systemic lymphomas. Common regimens include combinations like CHOP or CHOEP.
  • Targeted Therapies & Immunotherapy: Drugs, such as brentuximab vedotin, are highly effective for T-cells that express specific proteins like CD30.
  • Stem Cell Transplants: May be utilized, particularly for aggressive cases or patients who relapse after chemotherapy